ABSTRACT
The clinical manifestations of central nervous system (CNS) vasculitis are highly variable. In the absence of a positive CNS biopsy, CNS vasculitis is particularly suspected when markers of both vascular disease and inflammation are present. To facilitate the clinical and therapeutic approach to this rare condition, CNS vasculitis can be classified according to the size of the involved vessels. Vascular imaging is used to identify medium vessel disease. Small vessel disease can only be diagnosed with a CNS biopsy. Medium vessel vasculitis usually presents with focal neurological signs, while small vessel vasculitis more often leads to cognitive deficits, altered level of consciousness and seizures. Markers of CNS inflammation include cerebrospinal fluid pleocytosis or elevated protein levels, and vessel wall, parenchymal or leptomeningeal enhancement. The broad range of differential diagnoses of CNS vasculitis can be narrowed based on the disease subtype. Common mimickers of medium vessel vasculitis include intracranial atherosclerosis and reversible cerebral vasoconstriction syndrome. The diagnostic workup aims to answer two questions: is the neurological presentation secondary to a vasculitic process, and if so, is the vasculitis primary (i.e., primary angiitis of the CNS) or secondary (e.g., to a systemic vasculitis, connective tissue disorder, infection, malignancy or drug use)? In primary angiitis of the CNS, glucocorticoids and cyclophosphamide are most often used for induction therapy, but rituximab may be an alternative. Based on the available evidence, all patients should receive maintenance immunosuppression. A multidisciplinary approach is necessary to ensure an accurate and timely diagnosis and to improve outcomes for patients with this potentially devastating condition.
Subject(s)
Cerebrovascular Disorders , Intracranial Arteriosclerosis , Vasculitis, Central Nervous System , Humans , Adult , Vasculitis, Central Nervous System/diagnosis , Vasculitis, Central Nervous System/therapy , Vasculitis, Central Nervous System/complications , Seizures/complications , Inflammation/complicationsABSTRACT
BACKGROUND AND PURPOSE: 3D-TOF-MRA and DSA are 2 available tools to demonstrate neurovascular involvement in primary central nervous system vasculitis. We aimed to compare the diagnostic concordance of vessel imaging using 3D-TOF-MRA and DSA in patients with primary central nervous system vasculitis. MATERIALS AND METHODS: We retrospectively identified all patients included in the French primary central nervous system vasculitis cohort of 85 patients who underwent, at baseline, both intracranial 3D-TOF-MRA and DSA in an interval of no more than 2 weeks and before treatment initiation. Two neuroradiologists independently reviewed all 3D-TOF-MRA and DSA imaging. Brain vasculature was divided into 25 arterial segments. Concordance between 3D-TOF-MRA and DSA for the identification of arterial stenosis was assessed by the Cohen κ Index. RESULTS: Thirty-one patients met the inclusion criteria, including 20 imaged with a 1.5T MR unit and 11 with a 3T MR unit. Among the 25 patients (81%) with abnormal DSA findings, 24 demonstrated abnormal 3D-TOF-MRA findings, whereas all 6 remaining patients with normal DSA findings had normal 3D-TOF-MRA findings. In the per-segment analysis, concordance between 1.5T 3D-TOF-MRA and DSA was 0.82 (95% CI, 0.75-0.93), and between 3T 3D-TOF-MRA and DSA, it was 0.87 (95% CI, 0.78-0.91). CONCLUSIONS: 3D-TOF-MRA shows a high concordance with DSA in diagnostic performance when analyzing brain vasculature in patients with primary central nervous system vasculitis. In patients with negative 3T 3D-TOF-MRA findings, the added diagnostic value of DSA is limited.
Subject(s)
Angiography, Digital Subtraction/methods , Magnetic Resonance Angiography/methods , Vasculitis, Central Nervous System/diagnostic imaging , Adult , Aged , Cohort Studies , Female , Humans , Imaging, Three-Dimensional/methods , Male , Middle Aged , Retrospective StudiesABSTRACT
OBJECTIVES: To analyse the differences between patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA) entered into randomised clinical trials (RCTs) and those followed in large observational cohorts. METHODS: The main characteristics and outcomes of patients with generalised and/or severe GPA or MPA with a five-factor score ≥ 1 enrolled in the French Vasculitis Study Group (FVSG) or the US-Canadian-based Vasculitis Clinical Research Consortium cohorts were compared to those enrolled in one of 2 FVSG clinical RCTs (WEG91, WEGENT) or 3 European Vasculitis Society clinical trials (CYCLOPS, CYCAZAREM, IMPROVE). RESULTS: 657 patients (65.3% with GPA) in RCTs were compared to 437 in cohorts (90.6% with GPA). RCT patients were older at diagnosis than the cohort patients (56.6 ± 13.9 vs. 46.8 ± 17.3 years), had higher Birmingham vasculitis activity score (19.5 ± 9.1 vs. 16.9 ± 7.4), and more frequent kidney disease (84.0% vs. 54.9%) but fewer ear, nose, and throat symptoms (56.8% vs. 72.2%). At 56 months post-diagnosis, mortality and relapse rates, adjusted for age and renal function, were higher for patients with GPA in RCTs vs. cohorts (10.7% vs. 2.5% [p=0.001] and 22.5% vs. 15.6% [p=0.03], respectively) but similar for patients with MPA (6.2% vs. 6.6% [p=0.92] and 16.6% vs. 10.1% [p=0.39], respectively). CONCLUSIONS: Patients with GPA or MPA in RCTs and those in observational cohorts show important differences that should be remembered when interpreting results based on these study populations.
Subject(s)
Granulomatosis with Polyangiitis/epidemiology , Microscopic Polyangiitis/epidemiology , Observational Studies as Topic , Randomized Controlled Trials as Topic , Adult , Age Distribution , Aged , Antibodies, Antineutrophil Cytoplasmic/immunology , Cohort Studies , Female , Granulomatosis with Polyangiitis/complications , Granulomatosis with Polyangiitis/immunology , Humans , Kidney Diseases/etiology , Male , Microscopic Polyangiitis/complications , Microscopic Polyangiitis/immunology , Middle Aged , Myeloblastin/immunology , Otorhinolaryngologic Diseases/etiology , Patient Selection , Peroxidase/immunology , Severity of Illness IndexABSTRACT
HYPOTHESIS: Silica-polystyrene hybrid nanoparticles were synthesized by Pickering emulsion polymerization. The coupling effect of initiator type and silica surface charge was studied to exhibit the predominant role of electrostatic interactions in the synthesis mechanisms. EXPERIMENTS: Non-ionic hydrophobic initiator (2,2'-azobis(2-methylpropionitrile), AIBN) or anionic hydrophilic initiator (sodium persulfate, NaPS), and positively or negatively charged silica were used as reactants with styrene for Pickering emulsion polymerization. Their interactions were evaluated by Zeta potential measurements. The droplet size and the stability of the Pickering emulsions, and the hybrid particle morphology, surface coverage, size and agglomeration were evaluated by laser granulometry and microscopy. FINDINGS: Similar surface charge between negatively charged silica particles and an anionic initiator led to strong repulsions and thus to non-covered polystyrene nanoparticles. With positively charged silica, a high decoration was obtained due to attractive interactions between the inorganic and the organic phases, but a strong agglomeration was also observed. The use of a non-ionic initiator led to a homogeneous coverage with negatively charged silica. With positively charged silica micronic sizes were formed by following two different mechanisms. These data, by enriching the existing literature, led to a more complete and robust description of the emulsion polymerization synthesis for hybrid nanostructures.
ABSTRACT
Progressive multifocal encephalopathy (PML) is a rare demyelinating disorder targeting the central nervous system and resulting from JC virus reactivation. PML occurs in patients immunocompromised because of haematological malignancies, HIV infection or treatment with cytotoxic drugs. Herein, we describe PML occurring in 2 granulomatosis with polyangiitis (Wegener) patients treated with steroids and cyclophosphamide. The outcome was progressively favourable after immunosuppressant discontinuation for 1 patient and fatal for the other. Four previously reported GPA patients developed PML in the course of their disease. One of them improved gradually after immunosuppressant withdrawal. PML should be strongly suspected whenever unusual central neurological manifestations appear in this context. No effective treatment is available, but immunosuppressants should be discontinued if possible.
Subject(s)
Brain/drug effects , Cyclophosphamide/adverse effects , Granulomatosis with Polyangiitis/drug therapy , Immunosuppressive Agents/adverse effects , Leukoencephalopathy, Progressive Multifocal/chemically induced , Brain/pathology , Fatal Outcome , Granulomatosis with Polyangiitis/diagnosis , Humans , Leukoencephalopathy, Progressive Multifocal/diagnosis , Leukoencephalopathy, Progressive Multifocal/therapy , Magnetic Resonance Imaging , Male , Middle Aged , PrognosisABSTRACT
Central nervous system (CNS) vasculitides are a heterogeneous group of diseases that can lead to severe disability and death. Given the poor performance of available diagnostic procedures (magnetic resonance imaging, angiography and brain biopsy), the diagnosis of isolated CNS vasculitis is challenging. Differential diagnosis includes secondary CNS vasculitides (infection, cancer, drug exposure or systemic inflammatory disorders) and several non-inflammatory cerebral vasculopathies, such as the reversible cerebral vasoconstriction syndrome. Despite recent advances in neuroradiology and the publication of large retrospective case series, primary angiitis of the CNS remains a heterogeneous and challenging nosological entity. Prospective interdisciplinary studies are necessary to improve our approach to these patients.
Subject(s)
Central Nervous System/pathology , Vasculitis, Central Nervous System/diagnosis , Central Nervous System/diagnostic imaging , Diagnosis, Differential , Humans , Prognosis , RadiographyABSTRACT
Aggregation kinetics and gel formation in aqueous suspensions that undergo heteroaggregation are studied by means of Brownian dynamics simulations. The simulated system, described in a previous paper [M. A. Piechowiak, A. Videcoq, F. Rossignol, C. Pagnoux, C. Carrion, M. Cerbelaud, R. Ferrando, Langmuir, 2010, 26(15), 12540-12547.], is constituted of two kinds of synthesized, almost equally sized colloids: silica particles that are negatively charged and alumina-coated silica particles that are positively charged. The interactions between colloids are modeled by the DLVO potential. Several compositions are analyzed, from silica-rich to alumina-rich cases. The particle volume fraction φ is varied in the range 6-12%. The study of the aggregation kinetics allows us to clarify the effect of those variations on the clustering process. Gelation is analyzed by detection of spanning clusters in each x-, y-, z-direction of the cubic simulation box. Percolating networks start to be observed from φ = 7%, a low value of the volume fraction close to the solid volume fraction experimentally measured in sediments of those suspensions.
Subject(s)
Autoantibodies/blood , RNA Polymerase III/antagonists & inhibitors , Renal Insufficiency/epidemiology , Scleroderma, Systemic/epidemiology , Adult , Aged , Autoantibodies/immunology , Cohort Studies , Female , France/epidemiology , Humans , Male , Middle Aged , Prevalence , RNA Polymerase III/immunology , Renal Insufficiency/etiology , Renal Insufficiency/immunology , Scleroderma, Systemic/complications , Scleroderma, Systemic/immunologyABSTRACT
Lung fibrosis is considered a severe manifestation of microscopic polyangiitis (MPA). Antimyeloperoxidase (anti-MPO) antibodies in MPA patients' sera can activate MPO and lead to the production of reactive oxygen species (ROS). While high levels of ROS are cytotoxic, low levels can induce fibroblast proliferation. Therefore, we hypothesised that the oxidative stress induced by anti-MPO antibodies could contribute to lung fibrosis. 24 MPA patients (45 sera) were enrolled in the study, including nine patients (22 sera) with lung fibrosis. Serum advanced oxidation protein products (AOPP), MPO-induced hypochlorous acid (HOCl) and serum-induced fibroblast proliferation were assayed. AOPP levels, MPO-induced HOCl production and serum-induced fibroblast proliferation were higher in patients than in healthy controls (p<0.0001, p=0.0001 and p=0.0005, respectively). Increased HOCl production was associated with active disease (p=0.002). Serum AOPP levels and serum-induced fibroblast proliferation were higher in patients with active MPA and lung fibrosis (p<0.0001). A significant linear relationship between fibroblast proliferation, AOPP levels and HOCl production was observed only in patients with lung fibrosis. Oxidative stress, in particular the production of HOCl through the interaction of MPO with anti-MPO antibodies, could trigger the fibrotic process observed in MPA.
Subject(s)
Antibodies/immunology , Microscopic Polyangiitis/immunology , Oxidative Stress , Peroxidase/immunology , Peroxidase/metabolism , Pulmonary Fibrosis/immunology , Adult , Aged , Blood Proteins/metabolism , Cell Proliferation , Female , Fibroblasts/metabolism , Humans , Hypochlorous Acid/blood , Male , Microscopic Polyangiitis/enzymology , Middle Aged , Oxidation-Reduction , Pulmonary Fibrosis/enzymology , Severity of Illness IndexABSTRACT
OBJECTIVE: Little is known about systemic sclerosis (SSc)-related myopathy. We aimed to compare the clinical and immunological features of SSc patients with or without associated myopathy. METHODS: Forty SSc patients with myopathy, defined by myalgia or muscle weakness associated with creatine kinase (CK) more than five times the upper limit range or myopathic electromyography (EMG) or abnormal myopathology, were identified from the records of four French hospital centres. For each patient, we selected two SSc controls matched for cutaneous SSc form, sex, age at SSc onset, and disease duration. We performed a case-control study testing clinical and immunological SSc-related features for association with myopathy by conditional logistic regression. RESULTS: Muscle and SSc features of patients with myopathy did not differ significantly among the four centres of origin. Only four (10%) patients with SSc-associated myopathy had anti-polymyositis-scleroderma (PM-Scl) antibodies. Case-control univariate analysis revealed that reduced forced vital capacity (FVC) [odds ratio (OR) 3.0, 95% confidence interval (CI) 1.3-34.9], heart involvement, defined as clinical congestive heart failure, left ventricular ejection fraction (LVEF) < 60%, arrhythmia or conductive abnormalities (OR 2.9, 95% CI 1.3-6.5), and scleroderma renal crisis (OR 3.0, 95% CI 1.3-34.9) were significantly more frequent in patients with myopathy than in controls. Two autoantibodies were more frequent in patients with myopathy: anti-PM-Scl (OR 5.0, 95% CI 1.1-23.9) and anti-RNP (OR 6.9, 95% CI 1.1-64.4). Multivariate analysis retained two variables associated positively with myopathy [reduced FVC (OR 3.1, 95% CI 1.3-9.8) and heart involvement (OR 2.5, 95% CI 1.1-7.1)], while anti-centromere antibodies were associated negatively (OR 0.11, 95% CI 0.03-0.53). CONCLUSION: Heart monitoring of SSc patients with myopathy should be undertaken regularly because of the association of myocardial and skeletal myopathies in such patients.
Subject(s)
Muscular Diseases/etiology , Muscular Diseases/immunology , Scleroderma, Systemic/complications , Scleroderma, Systemic/immunology , Adolescent , Adult , Antibodies, Antinuclear/blood , Antibodies, Antinuclear/immunology , Arrhythmias, Cardiac/blood , Arrhythmias, Cardiac/immunology , Autoantibodies/blood , Autoantibodies/immunology , Case-Control Studies , Creatine Kinase/analysis , Female , France , Heart Failure/blood , Heart Failure/immunology , Humans , Male , Middle Aged , Muscle Weakness/enzymology , Muscle Weakness/etiology , Polymyositis/immunology , Renal Insufficiency/blood , Renal Insufficiency/etiology , Renal Insufficiency/immunology , Retrospective Studies , Stroke Volume/immunology , Vital Capacity , Young AdultABSTRACT
Fluorescent silica and alumina-like spherical particles with almost equal sizes are synthesized. Dilute aqueous suspensions are prepared with various ratios of those colloidal particles that exhibit opposite surface charges. These suspensions undergo heteroaggregation for a wide range of compositions. The structure of the formed aggregates is analyzed by means of confocal microscopy. The experimental results are compared to those of Brownian dynamics simulations in which the interactions between colloids are modeled by the DLVO potential. Good agreement between experiments and simulations is obtained.
Subject(s)
Aluminum Oxide/chemistry , Colloids/chemistry , Silicon Dioxide/chemistry , Microscopy, Confocal , Models, TheoreticalABSTRACT
OBJECTIVE: To assess the impact of digital ulcers (DUs) on disability and health-related quality of life (HRQoL) in systemic sclerosis (SSc). METHODS: Two hundred and thirteen patients with SSc were evaluated at four annual meetings of a patient society between 2004 and 2007 (n = 177) or during hospital stay (n = 36). HRQoL was assessed by the SF-36, global disability by the health assessment questionnaire (HAQ), hand disability by the Cochin Hand Function Scale (CHFS) and global hand and wrist mobility by the Kapandji index. RESULTS: Sixty-seven patients (31.4%) had at least one DU at the time of evaluation. Patients with DUs showed significantly more pitting scars (p<0.001) and calcinosis (p<0.0001) than others. Patients with DU had significantly greater HAQ (mean (SD) 1.218 (0.723) vs 0.930 (0.717), p = 0.008), CHFS (mean (SD) 27.38 (20.68) vs 16.73 (18.19), p<0.0001) and aesthetic prejudice (mean (SD) 6.1 (2.2) vs 3.9 (2.5), p<0.0001) scores than others. Hand and wrist mobility were significantly diminished in patients with DU (mean (SD) Kapandji score 75.3 (22.8) vs 81.7 (19.2), p<0.0001). The presence of a DU did not significantly alter the physical component but influenced the mental component (mean (SD) 43.38 (12.53) vs 39.58 (9.54), p = 0.026) of the SF36. CONCLUSION: Patients with SSc with DUs have reduced wrist and hand mobility, increased global and hand disabilities and decreased mental component of HRQoL.
Subject(s)
Fingers , Hand Dermatoses/etiology , Quality of Life , Scleroderma, Systemic/complications , Skin Ulcer/etiology , Adult , Aged , Disability Evaluation , Female , Hand Dermatoses/physiopathology , Hand Dermatoses/rehabilitation , Hand Joints/physiopathology , Humans , Male , Middle Aged , Outcome Assessment, Health Care , Prognosis , Range of Motion, Articular , Scleroderma, Systemic/physiopathology , Scleroderma, Systemic/rehabilitation , Skin Ulcer/physiopathology , Skin Ulcer/rehabilitation , Wrist Joint/physiopathologyABSTRACT
OBJECTIVE: To examine the diagnostic contributions of cardiac magnetic resonance imaging (CMRI) with delayed-enhancement (DE) in patients with Churg-Strauss syndrome (CSS). METHODS: We consecutively recruited 14 men and 6 women (mean age: 50+/-14 years) with CSS (mean disease duration: 4.5+/-3.6 years) and investigated them independently of the presence/absence of cardiac manifestations. Cardiac manifestations included heart failure in 6 patients, angina pectoris in 1, isolated ECG abnormality in 1, and isolated echocardiography and ECG abnormalities in 1. T1-weighted sequences were recorded after gadolinium injection to study myocardial DE. RESULTS: CMRI abnormalities were found in 13/20 patients, including all 9 patients with myocardial manifestations, and 4 of the 11 asymptomatic patients. DE was centromyocardial in 6 patients, subepicardial in 4, and subendocardial in 3. Most enhanced lesions were in the anteroseptal or lateral walls. Patients with myocardial symptoms and DE had higher transmyocardial wall DE scores (mean: 9.4 vs. 3.7, respectively; p=0.01) and lower left ventricular ejection fractions (mean: 42% vs. 59%; p=0.001) than asymptomatic patients with DE. CONCLUSION: CMRI with DE enabled the detection of myocardial involvement in CSS patients with or without clinical symptoms. The clinical relevance of CMRI abnormalities in patients without clinical, echocardiographic and ECG signs of cardiac involvement remains unknown and needs to be evaluated in future studies. It seems premature to intensify treatment or to prescribe systematically steroids and cytotoxic agents based on the presence of isolated CMRI anomalies.
Subject(s)
Churg-Strauss Syndrome/diagnosis , Heart Diseases/diagnosis , Magnetic Resonance Angiography/methods , Myocardium/pathology , Adolescent , Adult , Aged , Churg-Strauss Syndrome/complications , Churg-Strauss Syndrome/physiopathology , Coronary Angiography , Cross-Sectional Studies , Echocardiography , Female , Heart Diseases/etiology , Heart Diseases/physiopathology , Humans , Male , Middle Aged , Ventricular Dysfunction, Left/diagnosis , Ventricular Dysfunction, Left/etiologyABSTRACT
Primary angiitis of the central nervous system (PACNS) was first identified half a century ago, but it remains a rare and challenging disease. However, important advances have been made in the field of PACNS, mainly through recently published retrospective analyses of large groups of PACNS patients, and the consideration of reversible cerebral vasoconstriction syndrome as a distinct entity. Clinical manifestations of PACNS are variable and non-specific. Even though neuroimaging can be suggestive of vasculitis, only a leptomeningeal biopsy can definitively confirm vasculitis. However, a brain sample is taken in less than half the patients and cannot further help to distinguish between PACNS and secondary vasculitis of the central nervous system. Hence, physicians should be aware of all alternative diagnoses and PACNS mimickers, which are now well-known. Whereas prognosis now appears to be much better than for the first reported cases, probably attributable to the use of corticosteroids and immunosuppressants, mainly cyclophosphamide, the optimal therapeutic regimen, potentially based on each patient's characteristics, and its duration remain to be determined. Only multicenter studies and prospective therapeutic trials will be able to clarify these issues on therapy and eventually provide some data on PACNS physiopathogenesis, which remains a poorly explored domain.
Subject(s)
Cerebral Angiography , Magnetic Resonance Angiography , Tomography, X-Ray Computed , Vasculitis, Central Nervous System/diagnosis , Biopsy , Diagnosis, Differential , Drug Therapy, Combination , Glucocorticoids/therapeutic use , Humans , Immunosuppressive Agents/therapeutic use , Meninges/pathology , Neurologic Examination/methods , Patient Care Team , Prognosis , Vasculitis, Central Nervous System/drug therapy , Vasculitis, Central Nervous System/physiopathologyABSTRACT
OBJECTIVE: The aim of this study was to evaluate flu vaccination rates and influencing factors in patients with systemic inflammatory diseases. METHODS: All patients presenting with a systemic inflammatory disease and taking immunosuppressants, who were hospitalized or had consulted in our internal medicine department between January 2 and 31, 2006, were included in the study. The information concerning flu vaccination was collected with a standardized form. RESULTS: One hundred and thirty-seven patients (mean age 53.1+/-17.6years; 40 [29%] male patients) were included: 39 (28%) had received flu vaccination in 2005 including 14 (16.7%) of the 84 patients with no other indication for flu vaccination than IS-induced immunodepression and 25 (47.2%) of the 53 patients with other flu vaccination indication(s) (p<0.001). The most frequent reasons for non-vaccination were: absence of physician recommendation (58%), fear of adverse effects (35%) and concern on vaccine clinical effectiveness (5%). The vaccination rate was significantly higher (49%) among patients who remembered having received a voucher from the French National Health Insurance Agency versus 18% among those who did not (OR=4.2 [95%CI, 1.92-9.19] p<0.05). This correlation remained significant after adjustment for confounding factors in a logistic regression model. CONCLUSION: Influenza-vaccination coverage is low in patients receiving immunosuppressive therapy for systemic inflammatory diseases. We have to increase the influenza-vaccination coverage in this population.
Subject(s)
Immunosuppression Therapy , Influenza Vaccines , Vaccination/statistics & numerical data , Female , Humans , Immunosuppressive Agents/therapeutic use , Inflammation/drug therapy , Male , Middle AgedABSTRACT
OBJECTIVE: To describe the clinical presentation of the association between pulmonary fibrosis (PF) and systemic vasculitis related to antineutrophil cytoplasmic antibodies (ANCA-V). METHODS: 12 patients (three female, mean age 70.7 years) with ANCA-V associated with "idiopathic" PF were studied retrospectively. RESULTS: ANCA-V and PF were diagnosed simultaneously in eight cases; PF occurred earlier in three cases and during ANCA-V follow-up in one. No patient had intra-alveolar haemorrhage (IAH). ANCA were myeloperoxidase (MPO)-ANCA in all cases. Seven patients had blood eosinophilia at diagnosis. Two patients died during ANCA-V induction therapy. The respiratory status of five patients worsened and three of them died from exacerbation of end-stage respiratory failure. The five remaining patients had a stable respiratory status. CONCLUSION: The association of PF and ANCA-V does not seem to be fortuitous, even though their clinical evolutions are clearly not related. PF was the major cause of death.
Subject(s)
Antibodies, Antineutrophil Cytoplasmic/blood , Autoimmune Diseases/complications , Pulmonary Fibrosis/etiology , Vasculitis/complications , Aged , Autoimmune Diseases/immunology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Prognosis , Pulmonary Fibrosis/immunology , Retrospective Studies , Vasculitis/immunologyABSTRACT
OBJECTIVES: To describe the clinical characteristics and muscle pathological features of patients with systemic sclerosis (SSc) and myopathy and analyse their impact on muscle outcome. METHODS: Thirty-five patients with myopathy and available muscle biopsy were restrospectively investigated from the charts of four hospital centres. RESULTS: Twenty-six (74%) cases had diffuse SSc. The median time from SSc diagnosis was 5 years (range 0-23) at myopathy onset. The main myopathological features were mononuclear inflammation (63%), muscle atrophy (60%), necrosis (59%), regeneration (44%), fibrosis (24%) or microangiopathy (27%). After a median follow-up of 4.4 years, 24 patients (69%) showed complete or partial muscle remission. Only histological muscle inflammation was associated with good muscle prognosis in multivariate analysis (odds ratio 44.7, 95% CI 2.8 to 704.7). Patients without muscle inflammation had a poor response to corticosteroids (38% favourable response vs 90% in patients with inflammation). CONCLUSION: Muscle histopathology is critical in the therapeutic management of SSc-associated myopathy.
Subject(s)
Muscular Diseases/etiology , Scleroderma, Systemic/complications , Adult , Biopsy , Female , Glucocorticoids/therapeutic use , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Muscle, Skeletal/pathology , Muscular Diseases/drug therapy , Muscular Diseases/pathology , Prognosis , Retrospective StudiesABSTRACT
OBJECTIVE: To determine the frequency and risk factors of venous thromboembolic events (VTE) in Wegener's granulomatosis (WG), microscopic polyangiitis (MPA) and, the so far unstudied, Churg-Strauss syndrome (CSS) and polyarteritis nodosa (PAN). METHODS: Retrospective, systematic analysis and comparisons were made between the characteristics of patients in the VTE group and non-VTE group. 1130 patients with WG, MPA, CSS or PAN were identified from the French Vasculitis Study Group cohort. RESULTS: During a mean follow-up of 58.4 (45.8) months, 83 VTE occurred in 74 (6.5%) patients, with a median vasculitis-VTE diagnosis interval of 5.8 months (-3 to +156). VTE occurred in seven of 285 (2.5%) patients with PAN, 19 of 232 (8.2%) with CSS, 30 of 377 (8%) with WG and 18 of 236 (7.6%) with MPA. Multivariate analysis retained age, male sex or previous VTE or stroke with motor deficit as being associated with a higher VTE risk. The adjusted odds ratio (95% confidence interval) for VTE was 2.88 (1.27 to 6.50) for patients with WG, MPA or CSS compared with PAN (p = 0.01). CONCLUSIONS: Our results suggest that, like WG and MPA, patients with CSS are at a greater risk of VTE, than those with PAN. The reasons for this difference remain to be elucidated.